The subject of this publication is the conclusion of non-exclusive agreements on various contrast agents / drug combinations in the context of an active substance-spreading open house procedure, which are prescribed and handed over to the health insurance companies in Mecklenburg-Vorpommern in the SSB. As a rule, several active substances of the same indication are grouped into 13 groups. Further details can be found in Annex 11 to the call for proposals. Contrast media from any future contractor may be ordered by the contracted physicians who are informed about these economic sources of supply during the contract period, on the basis of the efficiency requirement; they are considered economical. Contract doctors are obliged to fulfill their need for contrast agents from a specialist group with the products of the contracting partner or one of the contractual partners. There is no substitution by the AOK.
Name: Ionic iodine containing highly osmolar water-soluble nephrotropic X-ray contrast agent.
Application: oral and / or rectal. Further possible
Application areas:
- X-ray diagnosis of the gastrointestinal tract, in particular, when the use of barium sulfate is undesirable or contraindicated and / or
- For X-ray of the colon and / or
- To study or delimitation of the gastrointestinal tract in computer tomography.
Pharmaceutical form: all authorized dosage forms of an active substance must be offered.
Concentration: all concentrations of an active substance must be offered.
Pack size: all approved pack sizes of one active substance must be offered.
Special feature: The application areas can also be covered with several products from one supplier.
Further information can be found in Annex 11 to the call for proposals.
Name: Paramagnetic extracellular macrocyclic contrast agent for MRI
Application: intraarticular application
Areas of application: direct magnetic resonance arthrography
NSF risk: low NSF risk class
Pharmaceutical form: all dosage forms of the active substance for this indication
Concentration: 0.0025 mmol / ml
Pack size: all pack sizes of the active substance for this indication
Further information can be found in Annex 11 to the call for proposals.
Name: Paramagnetic extracellular linear contrast media for MRI with renal excretion and partial biliary excretion
Application: intravenously. Further possible
Application areas:
- MRI of the liver
NSF risk: mean NSF risk
Pharmaceutical form: all authorized pharmaceutical forms of an active substance
Concentration: all concentrations possible
Pack size: all authorized pack sizes of the active substance
Further information can be found in Annex 11 to the call for proposals.
Name: Paramagnetic combined extracellular and hepatobiliary linear contrast media for MRI (excretion 50-50)
Application: Intravenous use. Further possible
Application areas:
- MRI of the liver
NSF risk: mean NSF risk class
Pharmaceutical form: all dosage forms of the active substance
Concentration: all concentrations possible
Pack size: all pack sizes of the active ingredient
Further information can be found in Annex 11 to the call for proposals.
Name: Barium sulphate-containing contrast agent
Application: Oral and / or intestinal and / or rectal use
application areas
- Representation of parts of the digestive tract and / or the entire digestive tract by CT and / or X-ray, further possible
Pharmaceutical form: all dosage forms of the active substance
Concentrations: all concentrations possible
Pack size: all pack sizes of the active ingredient
Further information can be found in Annex 11 to the call for proposals.
Name: Ionic iodine containing highly osmolar water-soluble nephrotropic X-ray contrast agent.
Application: Instillation. Further possible.
Application areas:
- retrograde urography,
- Micturition cytography.
Pharmaceutical form: all authorized dosage forms of an active substance must be offered.
Concentration: all concentrations of an active substance must be offered
Pack size: all approved pack sizes of one active substance must be offered
Further information can be found in Annex 11 to the call for proposals.
Name: Nonionic iodine-containing monomeric low-osmolar water-soluble nephrotropic X-ray contrast media
Application: intraarterial and intravenous. Further possible
application areas
- urography,
- phlebography, arteriography, angiography,
- angiocardiography,
- Digital subtraction angiography
CT contrast enhancement,
Pharmaceutical form: all authorized dosage forms of an active substance must be offered
Concentrations: must be offered cumulatively
1) 300 mg / ml - 320 mg / ml
2) 350 mg / ml - 370 mg / ml (all concentrations of an active substance must be offered, at least together all areas of application must be covered)
Pack size: all approved pack sizes of one active substance must be offered
Further information can be found in Annex 11 to the call for proposals.
Name: Nonionic iodine-containing monomeric low-osmolar water-soluble nephrotropic X-ray contrast media
Application: intrathecal. Further possible
Application areas:
- cervical, thoracic and lumbar myelography and radiculography,
- CT myelography
Pharmaceutical form: all authorized dosage forms of an active substance must be offered
Concentration:
200 mg / ml - 300 mg / ml (all concentrations of one active substance must be offered)
Pack size: all approved pack sizes of one active substance must be offered
Further information can be found in Annex 11 to the call for proposals.
Name: Nonionic iodine-containing monomeric low-osmolar water-soluble nephrotropic X-ray contrast media
Application: intra-arterial and intravenous and intracavitary. Further possible
Application areas:
- urography,
- Computed Tomography,
- angiography,
- digital subtraction angiography (DSA)
- angiocardiography, coronary arteriography, interventional coronary arteriography,
- Fistulography, galactography
Dosage Forms: All approved dosage forms of an active substance must be offered
Concentration: 400 mg / ml
Pack size: all approved pack sizes of one active substance must be offered
Further information can be found in Annex 11 to the call for proposals.
Name: Nonionic iodine-containing monomeric low-osmolar water-soluble nephrotropic X-ray contrast media
Application: intra-arterial and intravenous and intracavitary. Further possible
Application areas:
- urography,
- phlebography,
CT contrast enhancement,
- Digital subtraction angiography
Pharmaceutical form: all authorized dosage forms of an active substance must be offered
Concentration: 150 mg / ml-250 mg / ml, all concentrations of one active substance must be offered
Pack size: all approved pack sizes of one active substance must be offered
Further information can be found in Annex 11 to the call for proposals.
Name: Nonionic iodine-containing dimeric low-osmolar water-soluble nephrotropic X-ray contrast media
Application: intraarterial and intravenous. Further possible
Application areas:
- Cerebral angiography, abdominal angiography, peripheral arteriography, venography
- urography,
- contrast enhancement in computed tomography (CT)
Concentrations: must be offered cumulatively:
1) 270 mg / ml;
2) 320 mg / ml.
(all concentrations of an active substance must be offered, at least all areas of application must be covered together)
Pack size: all approved pack sizes of one active substance must be offered
Further information can be found in Annex 11 to the call for proposals.
Name: Paramagnetic extracellular linear contrast agent for MRI
Application: Intraarticular application
Application areas:
- direct magnetic resonance arthrography
NSF risk: high NSF risk class
Pharmaceutical form: all dosage forms of the active substance for this indication
Concentration: 0.002 mmol / ml
Pack size: all pack sizes of the active substance for this indication
Further information can be found in Annex 11 to the call for proposals.
Name: Paramagnetic extracellular macrocyclic contrast agent for MRI
Application: Intravenous. Further possible
NSF risk: low NSF risk
Application areas:
- Cranial and spinal magnetic resonance tomography,
- MRI of other organs (eg liver, kidney, pancreas, pelvis, lung, heart, chest, musculoskeletal system, others possible)
Pharmaceutical form: all authorized dosage forms of an active substance must be offered.
Concentration: all concentrations of an active substance must be offered.
Pack size: all approved pack sizes of one active substance must be offered
Further information can be found in Annex 11 to the call for proposals.